Overview
Clinical Meaning
Hormonal contraception primarily prevents pregnancy through suppression of the HPO axis.
AGPCNP
AGPCNP
Hormonal contraception primarily prevents pregnancy through suppression of the HPO axis. Combined hormonal contraceptives (CHC: pill, patch, ring) contain ethinyl estradiol and a progestin; the estrogen component suppresses FSH and follicular recruitment while the progestin suppresses the LH surge, preventing ovulation. Progestin also thickens cervical mucus (impeding sperm transport), thins the endometrium (reducing receptivity), and slows tubal motility. Progestin-only methods (POP, DMPA, implant, hormonal IUD) rely primarily on cervical mucus thickening and endometrial atrophy, with variable ovulation suppression (DMPA and implant reliably suppress ovulation; POP less consistently). The copper IUD creates a sterile inflammatory reaction in the endometrium, with copper ions toxic to sperm and ova, preventing fertilization. The levonorgestrel IUD releases progestin locally, primarily acting through cervical mucus and endometrial effects. US Medical Eligibility Criteria (MEC) categorize contraindications from 1 (no restriction) to 4 (unacceptable health risk).
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.